sorafenib has been researched along with calyculin a in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (calyculin a) | Trials (calyculin a) | Recent Studies (post-2010) (calyculin a) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 915 | 0 | 110 |
| Protein | Taxonomy | sorafenib (IC50) | calyculin a (IC50) |
|---|---|---|---|
| Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 0.0009 | |
| Serine/threonine-protein phosphatase PP1-gamma catalytic subunit | Homo sapiens (human) | 0.0182 | |
| Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B | Gallus gallus (chicken) | 0.0032 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biondi, RM; Brieger, A; Hinrichsen, I; Huhn, M; Passmann, S; Plotz, G; Weßbecher, IM; Zeuzem, S | 1 |
1 other study(ies) available for sorafenib and calyculin a
| Article | Year |
|---|---|
Phosphorylation-dependent signaling controls degradation of DNA mismatch repair protein PMS2.
Topics: Blotting, Western; Enzyme Inhibitors; HEK293 Cells; Humans; Marine Toxins; Mismatch Repair Endonuclease PMS2; Mutation; MutL Protein Homolog 1; MutL Proteins; Niacinamide; Oxazoles; Phenylurea Compounds; Phosphorylation; Proteolysis; Serine; Signal Transduction; Sorafenib; Threonine | 2017 |